Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins <i>G3</i> for the <sup>99m</sup>Tc-Based Imaging of HER2-Expressing Malignant Tumors-Reference-Cited by-同舟云学术

Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the ^99mTc-Based Imaging of HER2-Expressing Malignant Tumors

Published:2024-04-01 Issue:4 Volume:21 Page:1919-1932
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Larkina Maria¹²^ORCID,Varvashenya Ruslan¹²,Yuldasheva Feruza¹,Plotnikov Evgenii¹,Bezverkhniaia Ekaterina¹,Tretyakova Maria¹,Zelchan Roman¹³,Schulga Alexey¹⁴,Konovalova Elena¹⁴,Vorobyeva Anzhelika⁵^ORCID,Belousov Mikhail¹²,Orlova Anna⁵^ORCID,Tolmachev Vladimir⁶,Deyev Sergey¹⁴

Affiliation:

1. Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia

2. Department of Pharmaceutical Analysis, Siberian State Medical University, 634050 Tomsk, Russia

3. Department of Nuclear Medicine, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634009 Tomsk, Russia

4. Molecular Immunology Laboratory, Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia

5. Department of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, Sweden

6. Department of Immunology, Genetics and Pathology, Uppsala University, 75185 Uppsala, Sweden

Funder

Tomsk Polytechnic University

Cancerfonden

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c01173

Reference46 articles.

1. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers

2. Targeting Cell Cycle Progression in HER2+ Breast Cancer: An Emerging Treatment Opportunity

3. Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer

4. HER2-positive breast cancer

5. Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology